Geriatric

SLE (Systemic Lupus Erythematosus) using SLICC (Systemic Lupus Internation Collaborating Clinics) Criteria

Systemic Lupus Erythematosus (SLE) is a chronic, systemic autoimmune disease that can affect many parts of the body including skin, lungs, brain, heart, kidneys, joints, and blood vessels. SLE presentation can vary significantly between patients. Because of this, it can be challenging to identify a patient as having SLE. Between 300,000 and 2,000,000 people in the US are estimated to have SLE. Determination of an exact number of people affected is challenging as the disease is difficult to identify given the diverse presentations and the length of time it may take for symptoms to appear.

Owner Phenotyping Groups:

eMERGE Northwestern Group

View Phenotyping Groups:

eMERGE Mayo Group

eMERGE Phenotype WG

Final

Sleep Apnea Phenotype

The computable phenotype for the Sleep Apnea Patient Centered Outcomes Network uses existing and well established ICD codes for different types of sleep apnea including 327.23 (adult and pediatric obstructive sleep apnea), 780.51 (insomnia with sleep apnea), 780.53 (hypersomnia with sleep apnea), and 780.57 (unspecified sleep apnea).

Final

Type1 or Type 2 Diabetes Mellitus

Phenotyping algorithm for the identification of patients with type 1 or type 2 diabetes mellitus (DM) preoperatively using routinely available clinical data from electronic
health records.

View Phenotyping Groups:

American-Swiss Allergy Phenotyping Group

BioVU Phenotyping

Clostridium Difficile Colitis Phenotype Group

Denny’s Group at Vandy

eMERGE CCHMC Group

eMERGE CCHMC/BCH Group

eMERGE CHOP Group

eMERGE Columbia Group

eMERGE Geisinger Group

eMERGE GHC/University of Washington Group

eMERGE Harvard Group